A Study to Investigate the Safety, Reactogenicity, and Immunogenicity of mRNA-1469 Vaccine to Prevent Ebola-Bundibugyo Virus Disease in Healthy Adult Participants
Clinical trial NCT07737717 · RECRUITING
Trial details
- NCT number
- NCT07737717
- Sponsor
- ModernaTX, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-31
- Primary completion
- 2027-09-30
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.